337 related articles for article (PubMed ID: 11514225)
1. The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase.
Kwok BH; Koh B; Ndubuisi MI; Elofsson M; Crews CM
Chem Biol; 2001 Aug; 8(8):759-66. PubMed ID: 11514225
[TBL] [Abstract][Full Text] [Related]
2. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex.
Hehner SP; Hofmann TG; Dröge W; Schmitz ML
J Immunol; 1999 Nov; 163(10):5617-23. PubMed ID: 10553091
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory activity of parthenolide-depleted Feverfew (Tanacetum parthenium).
Sur R; Martin K; Liebel F; Lyte P; Shapiro S; Southall M
Inflammopharmacology; 2009 Feb; 17(1):42-9. PubMed ID: 19112586
[TBL] [Abstract][Full Text] [Related]
4. Feverfew extracts and the sesquiterpene lactone parthenolide inhibit intercellular adhesion molecule-1 expression in human synovial fibroblasts.
Piela-Smith TH; Liu X
Cell Immunol; 2001 May; 209(2):89-96. PubMed ID: 11446741
[TBL] [Abstract][Full Text] [Related]
5. Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice.
Saadane A; Masters S; DiDonato J; Li J; Berger M
Am J Respir Cell Mol Biol; 2007 Jun; 36(6):728-36. PubMed ID: 17272824
[TBL] [Abstract][Full Text] [Related]
6. Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities.
Mathema VB; Koh YS; Thakuri BC; Sillanpää M
Inflammation; 2012 Apr; 35(2):560-5. PubMed ID: 21603970
[TBL] [Abstract][Full Text] [Related]
7. [Molecular mechanisms of parthenolide's action: Old drug with a new face].
Koprowska K; Czyz M
Postepy Hig Med Dosw (Online); 2010 Mar; 64():100-14. PubMed ID: 20354259
[TBL] [Abstract][Full Text] [Related]
8. Parthenolide: from plant shoots to cancer roots.
Ghantous A; Sinjab A; Herceg Z; Darwiche N
Drug Discov Today; 2013 Sep; 18(17-18):894-905. PubMed ID: 23688583
[TBL] [Abstract][Full Text] [Related]
9. Biosynthesis and localization of parthenolide in glandular trichomes of feverfew (Tanacetum parthenium L. Schulz Bip.).
Majdi M; Liu Q; Karimzadeh G; Malboobi MA; Beekwilder J; Cankar K; Vos Rd; Todorović S; Simonović A; Bouwmeester H
Phytochemistry; 2011 Oct; 72(14-15):1739-50. PubMed ID: 21620424
[TBL] [Abstract][Full Text] [Related]
10. A sesquiterpene lactone from a medicinal herb inhibits proinflammatory activity of TNF-α by inhibiting ubiquitin-conjugating enzyme UbcH5.
Liu L; Hua Y; Wang D; Shan L; Zhang Y; Zhu J; Jin H; Li H; Hu Z; Zhang W
Chem Biol; 2014 Oct; 21(10):1341-1350. PubMed ID: 25200604
[TBL] [Abstract][Full Text] [Related]
11. Intra-specific variability of feverfew: correlations between parthenolide, morphological traits and seed origin.
Cutlan AR; Bonilla LE; Simon JE; Erwin JE
Planta Med; 2000 Oct; 66(7):612-7. PubMed ID: 11105564
[TBL] [Abstract][Full Text] [Related]
12. Role of cysteine residues of p65/NF-kappaB on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential.
García-Piñeres AJ; Lindenmeyer MT; Merfort I
Life Sci; 2004 Jul; 75(7):841-56. PubMed ID: 15183076
[TBL] [Abstract][Full Text] [Related]
13. Parthenolide, an inhibitor of the nuclear factor-κB pathway, ameliorates dextran sulfate sodium-induced colitis in mice.
Zhao ZJ; Xiang JY; Liu L; Huang XL; Gan HT
Int Immunopharmacol; 2012 Jan; 12(1):169-74. PubMed ID: 22155740
[TBL] [Abstract][Full Text] [Related]
14. Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells.
Berdan CA; Ho R; Lehtola HS; To M; Hu X; Huffman TR; Petri Y; Altobelli CR; Demeulenaere SG; Olzmann JA; Maimone TJ; Nomura DK
Cell Chem Biol; 2019 Jul; 26(7):1027-1035.e22. PubMed ID: 31080076
[TBL] [Abstract][Full Text] [Related]
15. Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro.
Lesiak K; Koprowska K; Zalesna I; Nejc D; Düchler M; Czyz M
Melanoma Res; 2010 Feb; 20(1):21-34. PubMed ID: 19949351
[TBL] [Abstract][Full Text] [Related]
16. Cytokine storm in COVID-19 and parthenolide: Preclinical evidence.
Bahrami M; Kamalinejad M; Latifi SA; Seif F; Dadmehr M
Phytother Res; 2020 Oct; 34(10):2429-2430. PubMed ID: 32472655
[TBL] [Abstract][Full Text] [Related]
17. Feverfew: weeding out the root of leukaemia.
Guzman ML; Jordan CT
Expert Opin Biol Ther; 2005 Sep; 5(9):1147-52. PubMed ID: 16120045
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines.
Wu C; Chen F; Rushing JW; Wang X; Kim HJ; Huang G; Haley-Zitlin V; He G
J Med Food; 2006; 9(1):55-61. PubMed ID: 16579729
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by parthenolide, a predominant sesquiterpene lactone in Tanacetum parthenium: involvement of nuclear factor-kappaB.
Kang BY; Chung SW; Kim TS
Immunol Lett; 2001 Jul; 77(3):159-63. PubMed ID: 11410248
[TBL] [Abstract][Full Text] [Related]
20. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products.
Heptinstall S; Awang DV; Dawson BA; Kindack D; Knight DW; May J
J Pharm Pharmacol; 1992 May; 44(5):391-5. PubMed ID: 1359053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
